Tag: Vaccine
BioAsia 2022 confers Genome Valley Excellence Award upon Dr. Drew Weissman
Dr. Weissman from the Department of Medicine, University of Pennsylvania receives the award for exemplary work done in developing mRNA COVID-19 vaccine
Zydus posts consolidated revenues of Rs. 3655 crores in Q3
The company filed 12 additional ANDAs with the USFDA during the quarter and received 9 new product approvals (including 5 tentative approvals) from the USFDA.
Bharat Biotech gets DCGI nod for Phase 3 clinical trials of...
The trials for 0.5 ml single dose of nasal vaccine will be conducted at nine locations in the country.
Providing people-centric high-tech solutions
ARTPARK at the Indian Institute of Science, Bangalore, developed an AI-driven platform that helped in the interpretation of images sent over WhatsApp, thus bringing about early interventions through rapid screening of COVID 19
COVAXIN booster dose study shows promising results
The phase 2, double-blind, randomised controlled COVAXIN trial demonstrated long-term safety with no serious adverse events
First-ever study in India claims Covid-19 vaccine cocktails are safe
Mix and match of different vaccines is safe and elicits robust antibody response, revealed the study conducted by AIG Hospitals
The first pilot study from India analyzing COVAXIN – COVISHEILD mixed doses
Apollo Hospitals joins the massive vaccination drive for 15-18 year age...
Registration of children in the eligible age group and categories and/or booking of vaccination time-slots in the Apollo 24/7 app has now begun
COVAXIN for children: Study demonstrates robust safety & immunogenicity in 2-18...
Whole-Virion inactivated SARS-CoV-2 Vaccine (BBV152) has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study. Neutralizing antibodies in children on an average 1.7 times higher than in adults......................
FICCI President hails expansion of Covid-19 vaccination, calls it a significant...
Opening the Booster or Precaution dose for the Healthcare and Frontline workers as well as the senior citizens with comorbidities will help us protect our high-risk population given the rising concerns from the forecasted 3rd COVID wave, said FICCI President, Sanjiv Mehta
COVAXIN approval for kids: India to vaccinate children aged 15-18 years...
As a precautionary measure, the healthcare workers and doctors will be given additional Covid-19 vaccine doses from January 10, 2022. Also, the people with co-morbidities and 60 years of age will get booster doses